| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3907032 | Urology | 2006 | 7 Pages |
Abstract
CTGF plays a crucial role in extracellular matrix production as a TGF-β1 downstream mediator in human prostate stromal cells, suggesting that CTGF blockade is likely to be a therapeutic target against benign prostatic hyperplasia.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Kazuya Suzuki, Kenji Obara, Kazuhiro Kobayashi, Kazutoshi Yamana, Vladimir Bilim, Toshiyuki Itoi, Kota Takahashi,